左右田 隆 | Central Research Division, Takeda Chemical Industries, Ltd.
スポンサーリンク
概要
関連著者
-
川松 豊
Central Research Division, Takeda Chemical Industries, Ltd.,
-
左右田 隆
武田薬品工業株式会社医薬研究本部
-
川松 豊
干寿製薬株式会社経営戦略室
-
左右田 隆
Central Research Division, Takeda Chemical Industries, Ltd.
-
水野 克利
Chemistry Research Laboratories Research and Development Division, Takeda Chemical Industries, Ltd.
-
水野 克利
Central Research Division, Takeda Chemical Ind., Ltd.,
-
水野 克利
Chemistry Research Laboratories Research And Development Division Takeda Chemical Industries Ltd.
-
目黒 寛司
浜理薬品工業株式会社
-
目黒 寛司
Central Research Division, Takeda Chemical Industries, Ltd.,
-
藤田 剛
防衛大学校 電気情報学群 電気電子工学科
-
藤田 剛
大阪産業振興機構tlo事業部
-
今宮 栄光
Central Research Division, Takeda Chemical Ind., Ltd.,
-
藤田 剛
オリエンタル酵母工業
-
多和田 紘之
Central Research Division, Takeda Chemical Industries, Ltd.,
-
杉山 泰雄
Central Research Division, Takeda Chemical Industries, Ltd.,
-
藤田 剛
Central Research Division, Takeda Chemical Industries, Ltd.,
-
杉山 泰雄
武田薬品工業株式会社 創薬研究本部
-
今宮 栄光
Resarch & Development Division Takeda Chemical Industries Ltd.
-
杉山 泰雄
武田薬品工業
-
多和田 紘之
Pharmaceutical Research Laboratories Ii Pharmaceutical Research Division Takeda Chemical Industries
-
杉山 泰雄
Central Research Division Takeda Chemical Industries Ltd.
-
藤田 剛
浜松医科大学第二外科
-
山本 佑二郎
Senju Pharmaceutical Co., Ltd.,
-
相沢 正博
Central Research Division, Takeda Chemical Industries, Ltd.
-
永岡 明伸
Central Research Division, Takeda Chemical Industries, Ltd.
-
平田 武夫
Central Research Division, Takeda Chemical Industries, Ltd.
-
牧 良孝
Central Research Division, Takeda Chemical Industries, Ltd.
-
牧 良孝
Central Research Division Takeda Chemical Industries Ltd.
-
永岡 明伸
Central Research Division Takeda Chemical Industries Ltd.
-
相沢 正博
Central Research Division Takeda Chemical Industries Ltd.
-
平田 武夫
Central Research Division Takeda Chemical Industries Ltd.
-
山本 佑二郎
Senju Pharmaceutical Co. Ltd.
著作論文
- Studies on Antidiabetic Agents. II. Synthesis of 5-[4-(1-Methylcyclohexylmethoxy)-benzyl] thiazolidine-2,4-dione (ADD-3878) and Its Derivatives
- Studies on Antidiabetic Agents. I. Synthesis of 5-[4-(2-Methyl-2-phenylpropoxy)-benzyl] thiazolidine-2,4-dione (AL-321) and Related Compounds
- New 1,4-Dihydropyridine Derivatives with Potent and Long-Lasting Hypotensive Effect
- Studies on Antidiabetic Agents. VI. Asymmetric Transformation of (±)-5-[4-(1-Methylcyclohexylmethoxy) benzyl]-2,4-thiazolidinedione (Ciglitazone) with Optically Active 1-Phenylethylamines
- Studies on Antidiabetic Agents. IV. Synthesis and Activity of the Metabolites of 5-[4-(1-Methylcyclohexylmethoxy) benzyl]-2,4-thiazolidinedione (Ciglitazone)
- Antiulcer Activity of 5-Benzylthiazolidine-2,4-dione Derivatives
- Studies on Antidiabetic Agents. III. 5-Arylthiazolidine-2,4-diones as Potent Aldose Reductase Inhibitors